![]() |
市场调查报告书
商品编码
1984894
全球婴幼儿营养食品市场:按性质、形式、类型、年龄层和分销管道划分-市场规模、产业动态、机会分析和预测(2026-2035 年)Global Infant Nutrition Market: By Type, Distribution Channel - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035 |
||||||
全球婴幼儿营养品市场正经历显着成长,预计2025年将达到610.3亿美元。这一成长趋势预计将持续强劲,到2035年市场规模预计将迅速扩张至1,620.8亿美元。预测期内,该市场复合年增长率将达到10.26%,显示儘管面临各种人口结构挑战,市场需求依然强劲且持续。这一显着增长不仅反映了人们对婴幼儿健康和营养意识的提高,也体现了消费者偏好的转变,他们更加重视产品的品质和专业的配方。
推动市场成长的最显着趋势之一是向高利润产品转型,这些产品强调临床功效和有机成分。现今的父母更了解产品,也更具鑑赏力,他们要求婴儿配方奶粉具有科学依据支持的功效,并且不含任何有害化学物质和合成添加剂。这种对优质化的关注意味着品牌正在大力投资研发,以开发出能够解决特定健康问题(例如过敏、消化健康和认知发育)的配方奶粉,同时满足消费者对有机和天然产品日益增长的需求。
婴儿营养品市场的「四大巨头」——雀巢、达能、雅培和利洁时——继续主导着该行业,合计占据超过60%的市场份额。这些大型公司越来越注重婴儿营养的“医疗化”,其战略核心是强调特定的健康益处,例如过敏管理,以及解决与婴儿生长相关的问题。
同时,美国的ByHeart、英国的Kendamil和中国的Biostime等新兴品牌正以截然不同的方式为产业带来全新视野。这些颠覆者并非着眼于药效,而是关註生产过程和原料的透明度。他们透过推广加工更少、成分洁净标示的产品,挑战传统的生产方式,以满足日益关注添加剂、人工成分以及婴幼儿食品整体纯度的父母的需求。
这些发展趋势正在婴幼儿营养品市场中形成一种有趣的两极化。一方面,老牌巨头继续以科学的医学声明和大规模创新为导向;另一方面,小规模、更灵活的品牌则专注于透明度、极简加工和天然成分,引领行业创新。这种张力正在推动持续创新和多元化发展,最终扩大消费者的选择范围,并塑造市场的未来方向。
主要成长驱动因素
「植物基2.0革命」正成为婴幼儿营养市场成长的关键驱动力。这项转变主要受两大社会和健康趋势的推动,这两大趋势正在重塑消费者的偏好和需求。推动这场革命的主要因素之一是婴幼儿牛奶蛋白过敏(CMPA)盛行率的上升。 CMPA是一种常见的食物过敏,影响全球越来越多的婴幼儿。因此,家长和医疗保健专业人员正在寻找不含牛奶蛋白的替代营养来源。 CMPA发病率的上升导致植物来源婴幼儿配方奶粉市场显着扩张。这些产品为患有CMPA的婴幼儿提供了安全有效的选择,确保他们获得必需的营养,而无需担心有害的过敏反应。
新机会的趋势
基于DNA的个人化营养正成为婴幼儿营养市场中一个充满前景且极具创新性的机会,拥有巨大的成长潜力。这种前沿方法利用基因组学和微生物组学的最新进展,提供高度客製化的营养解决方案,以满足每个婴儿的独特需求。透过分析婴儿的基因组成和肠道微生物组,製造商可以开发个人化配方奶粉和益生菌补充剂,以解决特定的营养缺乏问题,并支持婴儿的最佳健康状态。这种高度客製化的理念标誌着婴幼儿营养从传统的、千篇一律的配方奶粉向精准营养的重大转变,吸引了越来越多希望为孩子提供最佳呵护的父母的关注。
优化障碍
更严格的监管对婴儿配方奶粉市场的成长构成重大挑战。世界卫生组织(世卫组织)和联合国儿童基金会等国际组织长期以来一直倡导母乳哺育是婴儿的最佳营养来源,尤其是在出生后的前六个月。他们持续进行宣传活动,积极鼓励在这段关键时期减少配方奶粉的使用,强调母乳的健康益处以及过早替代的风险。这些努力影响了各国的政策和公众舆论,创造了一个要求配方奶粉生产商谨慎行事的环境。
The global infant nutrition market is experiencing substantial growth, with its valuation reaching USD 61.03 billion in 2025. This upward trajectory is expected to continue robustly, with projections indicating the market will soar to USD 162.08 billion by 2035. Such growth corresponds to a compound annual growth rate (CAGR) of 10.26% throughout the forecast period, highlighting strong and sustained demand despite various demographic challenges. This impressive expansion reflects not only the increasing awareness of infant health and nutrition but also the evolving preferences of consumers who are prioritizing quality and specialized formulations.
One of the most notable trends driving this market growth is the shift toward high-margin products that emphasize clinical validation and organic ingredients. Parents today are more informed and discerning, seeking infant nutrition options that provide scientifically backed benefits and are free from harmful chemicals or synthetic additives. This focus on premiumization means that brands are investing heavily in research and development to create formulas that address specific health concerns, such as allergies, digestive health, and cognitive development, while also catering to the growing demand for organic and natural products.
The Big Four players in the infant nutrition market-Nestle, Danone, Abbott, and Reckitt-continue to dominate the industry by collectively holding over 60% of the market share. These giants are intensifying their focus on the medicalization of infant nutrition, a strategy that revolves around emphasizing specific health claims such as allergy management and addressing growth-related concerns in infants.
Meanwhile, emerging brands like ByHeart in the United States, Kendamil in the United Kingdom, and Biostime in China are shaking up the sector by taking a very different approach. Rather than focusing primarily on medical claims, these disruptors are honing in on the processing and ingredient transparency angle. They challenge traditional manufacturing methods by promoting less processed, cleaner-label products that appeal to parents who are increasingly concerned about additives, artificial ingredients, and the overall purity of infant nutrition.
This dynamic creates a fascinating duality within the infant nutrition market: on one hand, the established giants continue to push forward with science-based medical claims and large-scale innovation, while on the other hand, smaller, agile brands disrupt the industry by focusing on transparency, minimal processing, and natural ingredients. This tension drives ongoing innovation and diversification, ultimately expanding choices for consumers and shaping the future direction of the market.
Core Growth Drivers
The Plant-Based 2.0 Revolution is becoming a significant force propelling growth within the infant nutrition market. This shift is largely driven by two key societal and health trends that are reshaping consumer preferences and demand. One major factor behind this revolution is the increasing prevalence of Cow's Milk Protein Allergy (CMPA) among infants. CMPA is a common food allergy that affects a growing number of babies worldwide, leading parents and healthcare providers to seek alternative nutrition sources that do not contain cow's milk proteins. This rising incidence has created a substantial market for plant-based infant formulas, which offer safe and effective options for infants with this allergy, ensuring they receive the necessary nutrients without risking adverse allergic reactions.
Emerging Opportunity Trends
DNA-based personalized nutrition is emerging as a promising and innovative opportunity within the infant nutrition market, offering significant potential for growth. This cutting-edge approach leverages advances in genomic and microbiome science to provide highly customized nutritional solutions tailored to the unique needs of each infant. By analyzing a baby's genetic makeup and gut microbiome, manufacturers can develop personalized formulas and probiotic supplements that address specific nutritional deficiencies and support optimal health outcomes. This level of customization represents a significant shift from traditional one-size-fits-all infant formulas toward precision nutrition, which is gaining increasing interest among parents seeking the best possible care for their children.
Barriers to Optimization
Regulatory tightening poses a significant challenge to the growth of the infant milk formula market. International organizations such as the World Health Organization (WHO) and UNICEF have long advocated for breastfeeding as the optimal source of nutrition for infants, especially during the first six months of life. Their ongoing campaigns actively discourage the use of formula feeding during this critical period, emphasizing the health benefits of breast milk and the risks associated with substituting it prematurely. These efforts have influenced national policies and public perception, creating a cautious environment for formula manufacturers.
By Formula Type, the infant milk formula segment firmly established itself as the dominant force within the infant nutrition market. This leadership position is largely the result of substantial investments in research and development by major industry players such as Nestle and Abbott. These companies have focused their efforts on creating formulas that closely replicate the nutritional profile of human breast milk, responding to the demand from parents seeking high-quality alternatives for their infants. The emphasis on scientific innovation has been pivotal in advancing the appeal and effectiveness of infant formulas, making them a trusted choice for many families around the world.
By Distribution Channel, hypermarkets and supermarkets emerged as the leading distribution channels, generating the largest share of revenue in their sector. Their dominant position is largely attributed to the trust they have built with consumers, especially in an environment where concerns about counterfeit products are on the rise. These large, established physical retailers serve as reliable verification hubs where customers feel confident that the products they purchase are genuine and safe. This trust is crucial in maintaining strong sales and customer loyalty, as consumers increasingly seek assurance regarding the authenticity and quality of the items they buy.
Geography Breakdown